✦ LIBER ✦
Is TIMP-1 immunoreactivity alone or in combination with other markers a predictor of benefit from anthracyclines in the BR9601 adjuvant breast cancer chemotherapy trial?
✍ Scribed by Alison F Munro, Annette Bartels, Eva Balslev…
- Book ID
- 120699090
- Publisher
- BioMed Central
- Year
- 2013
- Tongue
- English
- Weight
- 417 KB
- Volume
- 15
- Category
- Article
- ISSN
- 1465-5411
- DOI
- 10.1186/bcr3411
No coin nor oath required. For personal study only.